Cerebrolysin (Cerebrolysin®)

Neuropeptide Preparation · Neurological Recovery

Overview

Standardized neuropeptide preparation containing bioactive peptides and amino acids exhibiting neurotrophic and neuroprotective properties for stroke recovery, traumatic brain injury, and cognitive enhancement. Used clinically in 50+ countries.

IV/IM administration provides optimal bioavailability and brain penetration of neuropeptides and neurotrophic factors.

Meta-analyses show modest cognitive improvements, though clinical significance remains debated.

Multiple RCTs demonstrate significant ADAS-cog and CIBIC+ improvements.

Large meta-analysis shows significant NIHSS improvements; other studies found no functional benefit.

Largest meta-analysis (1,879 patients) shows NIHSS benefits; independent analysis found no mRS improvement.

Mechanism

IV/IM administration provides optimal bioavailability and brain penetration of neuropeptides and neurotrophic factors.

Meta-analyses show modest cognitive improvements, though clinical significance remains debated.

Research areas

Standardized neuropeptide preparation containing bioactive peptides and amino acids exhibiting neurotrophic and neuroprotective properties for stroke recovery, traumatic brain injury, and cognitive enhancement. Used clinically in 50+ countries.
IV/IM administration provides optimal bioavailability and brain penetration of neuropeptides and neurotrophic factors.
Meta-analyses show modest cognitive improvements, though clinical significance remains debated.
Multiple RCTs demonstrate significant ADAS-cog and CIBIC+ improvements.
Large meta-analysis shows significant NIHSS improvements; other studies found no functional benefit.
Largest meta-analysis (1,879 patients) shows NIHSS benefits; independent analysis found no mRS improvement.
Multiple trials including CAPTAIN series confirm GCS/GOS improvements.
Pilot trial shows promising 6-month outcomes; requires larger confirmatory studies.
Some studies show enhanced recovery; results vary significantly between trials.
Early administration within 72 hours shows better outcomes than delayed treatment.

Research notes

Generally well tolerated
Possible mild dizziness or agitation in early treatment
Severe allergic reactions (anaphylaxis, severe rash)
New onset seizure activity
Significant cardiovascular events during administration
Severe renal dysfunction or worsening kidney function
Epilepsy
Severe renal insufficiency
History of severe allergic reactions to porcine products

Pharmacokinetics

IV/IM administration provides optimal bioavailability and brain penetration of neuropeptides and neurotrophic factors.

References

FAQs

Does Cerebrolysin actually work for stroke recovery or is the evidence mixed?

Evidence is mixed. Large meta-analysis of 1,879 stroke patients showed NIHSS (neurological function) superiority, but an independent analysis found no significant improvement in modified Rankin Scale (functional outcomes). Cerebrolysin appears to have early neurological benefits without clear long-term functional recovery advantage.

Is Cerebrolysin safe given some published studies have been retracted?

Yes, several Cerebrolysin studies were retracted due to research misconduct. However, well-conducted meta-analyses by independent researchers confirm safety and modest efficacy signals. Rely on meta-analyses and well-designed RCTs rather than individual studies, some of which have credibility issues.

How quickly should Cerebrolysin be started after stroke or TBI for best results?

Early administration within 72 hours shows better outcomes than delayed treatment. Acute stroke protocols use 20-50mL daily IV infusion for 10-21 days. TBI protocols use similar dosing for 7-30 days depending on severity. Earlier initiation appears critical for neuroprotective benefit.

Can I mix Cerebrolysin with other IV solutions, vitamins, or medications?

No. Official guidelines contraindicate mixing Cerebrolysin with amino acid solutions, cardiovascular medications, or vitamin solutions in the same IV infusion. Compatibility issues exist, so use dedicated IV lines. Flush with sodium chloride before and after administration per protocol.